Invention Grant
- Patent Title: Mutated histidine decarboxylase and use thereof
-
Application No.: US16566236Application Date: 2019-09-10
-
Publication No.: US11713454B2Publication Date: 2023-08-01
- Inventor: Hiroki Yamaguchi , Masayuki Sugiki , Kunio Nakata
- Applicant: AJINOMOTO CO., INC.
- Applicant Address: JP Tokyo
- Assignee: AJINOMOTO CO., INC.
- Current Assignee: AJINOMOTO CO., INC.
- Current Assignee Address: JP Tokyo
- Agency: Cermak Nakajima & McGowan LLP
- Agent Shelly Guest Cermak
- Priority: JP 17047813 2017.03.13
- Main IPC: C12N9/88
- IPC: C12N9/88 ; C12N15/70 ; C12Q1/527

Abstract:
The present invention provides a mutated histidine decarboxylase suitable for a practical use. Specifically, the present invention provides a mutated histidine decarboxylase having at least one amino acid residue mutated as compared to a wild-type histidine decarboxylase, and having higher histidine decarboxylase activity and/or stability than the wild-type histidine decarboxylase, and also a use thereof. The mutated histidine decarboxylase has Motifs (1) to (6), and an amino acid residue in at least one motif thereof can be mutated. The mutated histidine decarboxylase can also have a mutation of at least one amino acid residue in an amino acid sequence designated by SEQ ID NO: 3 and in a homologous sequence thereto.
Public/Granted literature
- US20200002697A1 MUTATED HISTIDINE DECARBOXYLASE AND USE THEREOF Public/Granted day:2020-01-02
Information query